The experience of use of Mardil Zinc® Max in the course of treatment of skin benign disease

Abstract

The aim of the study was to investigate the efficacy of Mardil Zinc® Max in the course of treatment of skin benign disease. Under supervision there were 100 patients, including 46 patients with cutaneous horn, 14 patients with seborrheic keratosis, and 40 patients with HPV skin disorders (vulgar, flat, plantar and anogenital warts). All patients took Mardil Zinc® Max as a topical treatment. When applied to the preparation of skin benign diseases of non-viral origin recovery was observed in 100% of cases. In the treatment of patients with viral skin disorders full recovery was noted in 90% of cases.